[1]
Al-Ahmad, M., Nurkic, J., Maher, A., Arifhodzic, N. and Jusufovic, E. 2018. Tolerability of Omalizumab in Asthma as a Major Compliance Factor: 10-Year Follow Up. Open Access Macedonian Journal of Medical Sciences. 6, 10 (Oct. 2018), 1839–1844. DOI:https://doi.org/10.3889/oamjms.2018.394.